๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guangzhou
Clinical trial register · China

Clinical Trials in Guangzhou

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University451 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University181 Nanfang Hospital, Southern Medical University138 AstraZeneca133 Guangdong Provincial People's Hospital81
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
3318 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
NCT07277231Chronic Lymphocytic Leukemia
BeOne Medicines
Phase 3
500
Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Guiyang, Harbin, Zhengzhou
2026-01-22
Recruiting
Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery
NCT07269106Ophthalmic Surgery, Postoperative Pain Management, Opioid Analgesia
Zhongshan Ophthalmic Center, Sun Yat-sen University
Phase 4
204
Guangzhou, Kunming, Shanghai
2026-01-22
Recruiting
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
NCT07347600Locally Advanced Breast Cancer, Metastatic Breast Cancer
Hoffmann-La Roche
Observational
500
Xiamen, Lanzhou, Changchun, Wenzhou, Beijing, Chengdu, Chongqing, Guangzhou
2026-01-21
Recruiting
The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age
NCT07309562Small for Gestational Age
Xiamen Amoytop Biotech Co., Ltd.
Phase 3
141
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou
2026-01-20
Active, closed
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
NCT07230860Dermatitis, Atopic
Janssen Research & Development, LLC
Phase 2
189
Beijing, Changsha, Chengde, Chengdu, Guangzhou, Sanmenxia, Wuxi, Xi'an
2026-01-20
Not yet open
NK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC
NCT07318636Resectable Non-small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University
Phase 1
10
Guangzhou
2026-01-20
Recruiting
Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort Study
NCT07696832Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC, EGFR Mutation-negative and ALK Rearrangement-negative, Eastern Cooperative Oncology Group Performance Status (ECOG PS) Score of 0 to 2, No Prior Systemic Therapy Received for the Advanced or Metastatic Disease
Guangdong Association of Clinical Trials
Observational
265
Guangzhou
2026-01-20
Recruiting
A Phase II Study of SKB571 in Patients With Lung Cancer
NCT07230405Lung Cancer (Non-Small Cell)
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
295
Guangzhou, Zhengzhou
2026-01-19
Recruiting
Mapping of the Developmental Atlas of the Visual System and Research on Embryonic Neurogenesis Phenomena
NCT07688538Embryonic Development, Retinal Anomalies, Neural Development
Sheng Liu
Observational
200
Guangzhou
2026-01-16
Recruiting
Effect of Titrated Administration of Ciprofol on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic Abdominal Surgery: A Randomized Controlled Trial
NCT07328958Hypotension During Surgery
Sixth Affiliated Hospital, Sun Yat-sen University
Not applicable
500
Guangzhou
2026-01-16
Active, closed
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
NCT07230119Overweight , Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 3
755
Xuancheng, Beijing, Chongqing, Lanzhou, Guangzhou, Huizhou, Nanning, Handan
2026-01-16
Recruiting
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
NCT07195695Non-small Cell Lung Cancer
Boehringer Ingelheim
Phase 3
400
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan
2026-01-16
Not yet open
Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
NCT07231250DLBCL - Diffuse Large B Cell Lymphoma, Chemo-free Therapy, Bispecific Antibody
Li Zhiming
Phase 2
40
Guangzhou
2026-01-15
Recruiting
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
NCT07361289Hypertrophic Cardiomyopathy
Bristol-Myers Squibb
Observational
500
Beijing, Guangzhou, Jiazhuang, Harbin, Zhengzhou, Suzhou, Changchun, Dalian
2026-01-15
Recruiting
Electro-Acupuncture in Lung cancER : EALER Study
NCT07337096Non Small Cell Lung Cancer, Accupuncture, PD-1 Inhibitors
Guangzhou University of Traditional Chinese Medicine
Not applicable
424
Guangzhou, Nanjing
2026-01-15
Active, closed
A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)
NCT07266090SLE - Systemic Lupus Erythematosus
Viatris Pharmaceuticals Co., Ltd.
Phase 2
15
Guangzhou, Shijiazhuang, Luoyang, Zhengzhou, Jiujiang, Nanchang, Beijing
2026-01-14
Recruiting
Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)
NCT07317934Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Innostellar Biotherapeutics Co.,Ltd
Phase 3
388
Hefei, Beijing, Chongqing, Guangzhou, Shantou, Zhongshan, Xingtai, Harbin
2026-01-14
Recruiting
Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma
NCT07324824Hepatocellular Carcinoma, Neoadjuvant Therapy, Sintilimab, Bevacizimab
Sun Yat-sen University
Phase 2
37
Guangzhou
2026-01-14
Recruiting
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
NCT07190300Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Novartis Pharmaceuticals
Phase 1/2
181
Guangzhou
2026-01-13
By invitation
Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT
NCT07690306Prostate Cancer (Diagnosis)
Xiangya Hospital of Central South University
Observational
1,500
Beijing, Guangzhou, Jinan, Shanghai
2026-01-13
Recruiting
LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
NCT07325539Nasopharyngeal Cancinoma (NPC), Nasopharangeal Cancer
Sun Yat-sen University
Phase 2
55
Guangzhou, Shenzhen
2026-01-12
Recruiting
A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors
NCT07222969Advanced Solid Tumors
Vibrant Sciences Limited
Phase 1/2
146
Guangzhou
2026-01-12
Recruiting
Comparison of Efficacy Between De-escalated Surgery and Standard Surgery After Neoadjuvant Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07369882Locally Advanced Head and Neck Squamous Cell Carcinoma
Qunxing Li,MD
Not applicable
60
Guangzhou
2026-01-12
Recruiting
Diagnostic Biomarkers for Checkpoint Inhibitor-related Pneumonitis
NCT07340892Checkpoint Inhibitor-related Pneumonitis
Zhou Chengzhi
Observational
60
Guangzhou
2026-01-10
Active, closed
A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis
NCT07321951Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
201
Guangzhou, Hangzhou
2026-01-09
Recruiting
A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors
NCT07131202Advanced Solid Tumors
Suzhou Forlong Biotechnology Co., Ltd
Phase 1/2
130
Guangzhou
2026-01-08
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
Phase 3
1,410
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Huizhou, Jiangmen, Nanning
2026-01-06
Recruiting
Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL
NCT07441993Marginal Zone Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
30
Guangzhou, Zhengzhou, Wuhan, Xiangyang, Changsha, Nanjing, Nantong, Nanchang
2026-01-05
Not yet open
A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer
NCT07235618Locally Advanced or Metastatic Breast Cancer
Sun Yat-sen University
Phase 2
50
Guangzhou
2026-01-05
Recruiting
Efficacy and Safety Comparison Between Intensified Therapy and Conversion Therapy For Advanced HCC After Failure of First-line
NCT07501351Hepatocellulcar Carcinoma
Sun Yat-sen University
Phase 2
80
Guangzhou
2026-01-05
Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
NCT07063745Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Bristol-Myers Squibb
Phase 2/3
590
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shenzhen, Nanning
2026-01-02
Recruiting
Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma
NCT07371611Locally Advanced Oral Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma (OSCC)
Qunxing Li,MD
Phase 3
104
Guangzhou
2026-01-01
Active, closed
DIEP-MDS for Risk Stratification of Flap Vascular Compromise and Failure in Breast Reconstruction
NCT07761390Breast Neoplasms, Breast Reconstruction, Postoperative Complications
Zhuliling
Observational
1,500
Xiamen, Dongguan, Guangzhou, Huizhou, Meizhou, Shantou, Shanwei, Shaoguan
2026-01-01
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT07349498Hematopoietic Stem Cell Transplantation, Transplant Complication, Cardiovascular Events
Peking University People's Hospital
Observational
10,000
Beijing, Chongqing, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Xi'an
2026-01-01
Not yet open
Efficacy and Safety of Reperfusion Therapy for Minor Ischemic Stroke in China
NCT07322835Minor Ischemic Stroke
First Affiliated Hospital, Sun Yat-Sen University
Observational
5,400
Guangzhou
2026-01-01
Not yet open
Stereotactic Aspiration of Brain Stem Hematoma
NCT07300501Brain Stem Hematoma
First Affiliated Hospital of Zhejiang University
Not applicable
300
Hangzhou, Changsha, Guangzhou, Jinan, Shanghai, Shenzhen, Taizhou, Wenzhou
2026-01-01
Recruiting
Rapid Construction of Tissue-engineered Skin for Repairing Difficult-to-heal Wounds
NCT07562230Wounds and Injuries / Mortality
First Affiliated Hospital, Sun Yat-Sen University
Not applicable
1,000
Guangzhou
2026-01-01
Recruiting
Large Language Models Assist in Tumor MDT
NCT07504367Lung Cancer, Breast Cancer, Colorectal Cancer, Stomach Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
60
Guangzhou
2026-01-01
Active, closed
Clinical Study on the Effect of Umbilical Cord Mesenchymal Stem Cell Exosomes on Endometrial Repair of Intrauterine Adhesions
NCT07416578Intrauterine Adhesions, Exosomes
Sixth Affiliated Hospital, Sun Yat-sen University
Not applicable
60
Guangzhou
2026-01-01
Recruiting
Magnetic Tracking and ECG-Guided Tip Confirmation System for PICCs
NCT07369427Peripherally Inserted Central Catheters
Sun Yat-sen University
Observational
176
Guangzhou
2026-01-01
Active, closed
PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure
NCT07409259Acute-on-Chronic Liver Failure (ACLF)
Third Affiliated Hospital, Sun Yat-Sen University
Phase EARLY_PHASE1
20
Guangzhou
2026-01-01
Not yet open
Prenatal Exercise Including Perineal Massage and Maternal-Neonatal Outcomes
NCT07314502Postpartum Urinary Incontinence, Postpartum Depression (PPD), Neonatal Complications, Gestational Diabetes
South China Normal University
Not applicable
2,000
Guangzhou
2026-01-01
Recruiting
A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer
NCT07103395Lung Cancer (NSCLC)
Sun Yat-sen University
Phase 2
56
Guangzhou
2026-01-01
Recruiting
A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial)
NCT07669220Rectal Adenocarcinoma, High-risk Locally Advanced, Short-course Radiotherapy (SCRT), Immunotherapy
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
76
Guangzhou
2026-01-01
Recruiting
A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
NCT07303803MASH - Metabolic Dysfunction-Associated Steatohepatitis, T2DM (Type 2 Diabetes Mellitus)
Shanghai Jiao Tong University School of Medicine
Phase 2
300
Beijing, Chongqing, Fuzhou, Guangzhou, Wuhan, Shiyan, Changsha, Changchun
2026-01-01
By invitation
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
NCT07353294Bladder Urothelial Carcinoma, Lymph Node Metastasis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1
12
Guangzhou
2026-01-01
Not yet open
Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
NCT07376057Prostatic Neoplasms, Castration-Resistant
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
150
Guangzhou
2026-01-01
Not yet open
Prospective Cohort Study on PEG-IFN-ฮฑ-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B
NCT07231276HBV, Chronic Hepatitis B Virus
Nanfang Hospital, Southern Medical University
Phase 4
113
Guangzhou
2026-01-01
Not yet open
Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification
NCT07199101Radiation Dose Reduction
Beijing Children's Hospital
Not applicable
2,650
Beijing, Chongqing, Guangzhou, Baoding, Zhengzhou, Wuxi, Changchun, Xi'an
2026-01-01
Recruiting
Guangzhou Community Elderly Fall Prevention Appropriate Technology Promotion Project
NCT07458958Fall, Old Age
Guangzhou Center for Disease Control and Prevention
Not applicable
320
Guangzhou
2026-01-01
Not yet open
A Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT07354984Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Sun Yat-sen University
Phase 2
30
Guangzhou
2026-01-01
Not yet open
A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients
NCT07338396Non Small Cell Lung Cancer NSCLC
Guangzhou University of Traditional Chinese Medicine
Observational
3,000
Beijing, Guangzhou, Weihui, Shanghai, Chengdu
2026-01
Not yet open
Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations
NCT07328919Intrahepatic Cholangiocarcinoma (Icc), Advanced Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc.
Phase 3
138
Hefei, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Nanchang
2026-01
Not yet open
Effect of Inhaled Nitric Oxide Therapy in Adults With Moderate-to-Severe Acute Respiratory Distress Syndrome
NCT07334873ARDS (Moderate or Severe)
Nanfang Hospital, Southern Medical University
Not applicable
536
Guangzhou
2026-01
Recruiting
Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
NCT07309952Locally Advanced Non-Small Cell Lung Cancer, Stage IIIb Non-small Cell Lung Cancer, Stage IIIC Non-Small Cell Lung Cancer
Yang Hong
Phase 2
28
Guangzhou
2025-12-31
Recruiting
Efficacy and Safety of Extended-Dose Interval Immunotherapy Versus Standard-Dose Interval Immunotherapy for Advanced Triple-Negative Breast Cancer
NCT07401537Triple -Negative Breast Cancer, Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
416
Guangzhou
2025-12-31
Recruiting
Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis
NCT07360808Systemic Sclerosis (SSc), Hand Dysfunction
Cytori Therapeutics
Not applicable
48
Guangzhou, Shanghai
2025-12-31
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07221357Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb
Phase 2/3
990
Hefei, Chongqing, Fuzhou, Fuzhou Fujian, Guangzhou, Shenzhen, Nanning, Tianjin
2025-12-31
Recruiting
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
NCT07310095Crohn Disease
Xian-Janssen Pharmaceutical Ltd.
Phase 4
78
Guangzhou, Hangzhou, Hefei, Shanghai
2025-12-30
Not yet open
Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue
NCT07276854Gastric Cancer, Molecular Imaging
Nanfang Hospital, Southern Medical University
Observational
32
Guangzhou
2025-12-30
Not yet open
Effect of Different Oxygen Concentrations Before Extubation After General Anesthesia on Hypoxemia After Extubation in Post-anesthesia Care Unit
NCT07293286Hypoxemia
Sixth Affiliated Hospital, Sun Yat-sen University
Not applicable
590
Guangzhou
2025-12-30
Not yet open
Efficacy of Diacylglycerol Oil on Metabolic Risk Factors in Prediabetes
NCT07289880Prediabetes
The First Affiliated Hospital of Guangdong Pharmaceutical University
Not applicable
40
Guangzhou
2025-12-30
Not yet open
PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer
NCT07277842Locally Advanced Low Rectal Adenocarcinoma, pMMR (Microsatellite Stable Rectal Cancer)
Sun Yat-sen University
Phase 3
382
Guangzhou
2025-12-29
Recruiting
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
NCT07143045EGFR Mutant Advanced Non-small Cell Lung Cancer, Central Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd.
Observational
800
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Foshan, Guangzhou, Meizhou
2025-12-29
Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRฮฑ-high and AZD5335 vs. Chemotherapy in FRฮฑ-low Platinum-resistant Ovarian Cancer
NCT07218809Epithelial Ovarian Cancer
AstraZeneca
Phase 3
1,100
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2025-12-29
Recruiting
The Safety and Efficacy of ZVS106e in the Treatment of IRDs Caused by Biallelic Mutations in ABCA4
NCT07241169Stargardt
Zhongshan Ophthalmic Center, Sun Yat-sen University
Phase EARLY_PHASE1
9
Beijing, Guangzhou
2025-12-29
Recruiting
Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids
NCT07610616HER2 Positive OR TROP2 Positive Non-Small Cell Lung Cancer
Guangzhou Institute of Respiratory Disease
Observational
10
Guangzhou
2025-12-28
Recruiting
Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients
NCT07266116Systemic Light Chain Amyloidosis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1/2
70
Beijing, Chongqing, Fuzhou, Guangzhou, Shenzhen, Guiyang, Baoding, Harbin
2025-12-26
Recruiting
QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT
NCT07327788Hepatecellular Carcinoma, RALOX-HAIC๏ผˆHepatic Arterial Infusion Chemotherapy With Raltitrexed and Oxaliplatin, Bevacizumab, Type VP3/4 Portal Vein Tumor Thrombosis
Nanfang Hospital, Southern Medical University
Phase 2
38
Guangzhou
2025-12-25
Recruiting
A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy
NCT07235202Pancreatic Ductal Adenocarcinoma (PDAC)
Shenzhen Majory Biotechnology Co., Ltd.
Phase 1/2
45
Beijing, Guangzhou, Harbin, Changchun
2025-12-24
Recruiting
JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.
NCT07284134Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
560
Hefei, Beijing, Fuzhou, Lanzhou, Wuwei, Guangzhou, Meizhou, Shantou
2025-12-24
Recruiting
A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor
NCT07275242Solid Tumor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
107
Guangzhou
2025-12-23
Not yet open
Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC
NCT07294261Local Advanced or Metastatic NSCLC
Sun Yat-sen University
Phase 2
69
Guangzhou
2025-12-23
Recruiting
A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
NCT07675746Dravet Syndrome (DS)
Second Affiliated Hospital of Guangzhou Medical University
Phase EARLY_PHASE1
8
Guangzhou
2025-12-22
Recruiting
A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
NCT07283367CRC
Hansoh BioMedical R&D Company
Phase 1/2
502
Guangzhou
2025-12-22
Not yet open
SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer
NCT07297030Rectal Cancer
Sun Yat-sen University
Phase 2
37
Guangzhou
2025-12-20
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07225946Prostatic Neoplasms, Castration-Resistant
Janssen Research & Development, LLC
Phase 3
800
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanjing, Shanghai, Tianjin
2025-12-19
Active, closed
FANS-Assisted Mini-PCNL for Complex Renal Stones
NCT07332286Kidney Stones
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
30
Guangzhou
2025-12-19
Not yet open
Prospective Geometric Analysis of Ultra-Widefield OCTA Characteristics in Central Serous Chorioretinopathy Patients
NCT07347119Central Serous Chorioretinopathy (CSC)
Sun Yat-sen University
Observational
120
Guangzhou
2025-12-18
Recruiting
Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors
NCT07292038Cancers
NucMito Pharmaceuticals Co. Ltd.
Phase 1
30
Xiamen, Guangzhou, Zhengzhou
2025-12-18
Recruiting
Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients
NCT07314294Metastatic Colorectal Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 2
54
Beijing, Guangzhou
2025-12-18
Recruiting
Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study
NCT07328243Thyroid Cancer Patients, Lymph Node Metastasis
Tian'an Jiang
Not applicable
85
Guangzhou, Hangzhou
2025-12-17
Recruiting
A Phase โ… /โ…กa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
NCT07228247Solid Tumors, Adult
Hutchmed
Phase 1/2
147
Beijing, Changsha, Guangzhou, Hefei, Shanghai, Shenyang, Zhengzhou
2025-12-16
Recruiting
A Phase II Trial of LM103 in Advanced Melanoma
NCT07310784Advanced Melanoma
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase 2
92
Beijing, Fuzhou, Guangzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Changchun
2025-12-16
Recruiting
Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers
NCT07260708Advanced Cancers
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1
42
Beijing, Guangzhou, Zhengzhou, Changsha, Nanjing, Nanchang, Dalian, Jinan
2025-12-16
Recruiting
Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid
NCT07311772Nasopharyngeal Cancinoma (NPC), Radiation-induced Oral Mucositis
Sun Yat-sen University
Phase 3
386
Beijing, Fuzhou, Guangzhou, Shantou, Zhuhai, Nanning, Wuzhou, Changsha
2025-12-16
Recruiting
A Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
NCT07323173Systemic Lupus Erythematosus
Nanjing Leads Biolabs Co.,Ltd
Phase 1
117
Bengbu, Beijing, Guangzhou, Changsha, Nanjing, Pingxiang, Shanghai, Taiyuan
2025-12-16
Not yet open
Multicenter Study on Early Arterial Changes in Prediabetic Patients Evaluated by Ultra-High-Frequency Ultrasound
NCT07271745Prediabetes
Chunyan Ma
Observational
1,740
Guangzhou, Nanning, Harbin, Jiamusi, Zhengzhou, Nanjing, Nanchang, Changchun
2025-12-15
Recruiting
Superior HypogastrIc plExus bLock During Laparoscopic Colorectal Cancer Surgery
NCT07579780Colorectal Cancer (Diagnosis), Laparoscopic Surgery, Superior Hypogastric Plexus Block
Sixth Affiliated Hospital, Sun Yat-sen University
Not applicable
170
Guangzhou
2025-12-15
Recruiting
A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib Monotherapy
NCT07375316Non Small Cell Lung Cancer
Guangdong Association of Clinical Trials
Phase 2
120
Guangzhou, Meizhou, Shantou, Shenzhen
2025-12-15
Not yet open
Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer
NCT07246317Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
188
Guangzhou, Shijiazhuang, Luoyang, Nanyang, Chengdu, Tianjin, Jiaxing
2025-12-15
By invitation
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult Subjects
NCT07324434Hyperuricemia With or Without Gout
Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd.
Phase 1
69
Guangzhou
2025-12-15
Recruiting
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
NCT07276581Rheumatoid Arthritis
AstraZeneca
Phase 2
320
Beijing, Changchun, Changsha, Guangzhou, Jiujiang, Kunming, Linyi, Nanchong
2025-12-15
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
NCT07282600Overweight, Obesity
Eli Lilly and Company
Phase 3
1,035
Beijing, Chengdu, Chongqing, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang
2025-12-15
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
450
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin
2025-12-12
Recruiting
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
NCT07222267Breast Cancer, Advanced Solid Tumor
BeOne Medicines
Phase 1
86
Beijing, Chongqing, Xiamen, Guangzhou, Harbin, Nanjing, Shanghai, Tianjin
2025-12-11
Recruiting
A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+
NCT07326215Acute Respiratory Distress Syndrome, Acute Kidney Injury
Vantive Health LLC
Not applicable
99
Beijing, Guangzhou, Shenzhen, Harbin, Nanjing, Nanchang, Shanghai, Chengdu
2025-12-11
Recruiting
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
NCT07222800Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms, Neoplasms by Site
Pfizer
Phase 3
800
Hefei, Beijing, Chongqing, Guangzhou, Meizhou, Nanning, Wuhan, Changsha
2025-12-11
Recruiting
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
NCT07302360Colitis, Ulcerative
Xian-Janssen Pharmaceutical Ltd.
Observational
200
Beijing, Changzhou, Guangzhou, Hangzhou, Nanjing, Shijiazhuang, Tianjin
2025-12-11
Not yet open
Preventive Efficacy of Bergmann Enema for Acute Radiation-induced Rectal Injury in Rectal Cancer Patients Undergoing Short-course Radiotherapy
NCT07302126Acute Radiation Enteritis
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
40
Guangzhou
2025-12-11
Rows per page Showing 601–700 of 3318
Previous 5 6 7 8 9 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/guangzhou?page=7

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.